{"nct_id":"NCT03303066","title":"Efficacy and Safety of FG-4592 for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome (MDS)","status":"COMPLETED","status_verified_date":"2023-04","start_date":"2018-06-06","start_date_type":"ACTUAL","primary_completion_date":"2023-01-11","primary_completion_date_type":"ACTUAL","completion_date":"2023-02-08","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["FGEN"]}